Natural Born Killers: NK Cells in Cancer Therapy

by S. Elizabeth Franks, Benjamin Wolfson, James W. Hodge
Published 2020-07-01

Stay on Target: Reengaging Cancer Vaccines in Combination Immunotherapy

by Benjamin Wolfson, S. Elizabeth Franks, James W. Hodge
Published 2021-05-01

From Immunogenic Cell Death to Immunogenic Modulation: Select Chemotherapy Regimens Induce a Spectrum of Immune-Enhancing Activities in the Tumor Microenvironment

by Kellsye P. Fabian, Benjamin Wolfson, James W. Hodge
Published 2021-08-01

Exploiting off-target effects of estrogen deprivation to sensitize estrogen receptor negative breast cancer to immune killing

by Jeffrey Schlom, James W Hodge, Benjamin Wolfson, Michelle R Padget
Published 2021-07-01

Correction to: Immunotherapy Utilizing the Combination of Natural Killer– and Antibody Dependent Cellular Cytotoxicity (ADCC)–Mediating Agents with Poly (ADP-ribose) polymerase (PA...

by Kathleen E. Fenerty, Michelle Padget, Benjamin Wolfson, Sofia R. Gameiro, Zhen Su, John H. Lee, Shahrooz Rabizadeh, Patrick Soon-Shiong, James W. Hodge
Published 2019-09-01

Immunotherapy utilizing the combination of natural killer– and antibody dependent cellular cytotoxicity (ADCC)–mediating agents with poly (ADP-ribose) polymerase (PARP) inhibition...

by Kathleen E. Fenerty, Michelle Padget, Benjamin Wolfson, Sofia R. Gameiro, Zhen Su, John H. Lee, Shahrooz Rabizadeh, Patrick Soon-Shiong, James W. Hodge
Published 2018-11-01